Navigation Links
RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
Date:12/10/2018

Today, RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. (TRT) announce a strategic alliance to advance their shared goal of accelerating the development of the Regenerative Medicine field. This alliance will be focused on applying RoosterBio’s unique scale-up bioprocess systems to TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, it is anticipated that these technology platforms will establish a new level of perivascular stromal cell manufacturing productivity, driving commercially-relevant lot sizes in scalable production platforms, thus creating newfound efficiencies in Regenerative Medicine.

“Tissue Regeneration Therapeutics have established themselves as leaders in cord tissue perivascular cells, and we are excited to collaborate to help drive cell manufacturing productivity within their unique technology platform.” said Margot Connor, RoosterBio’s CEO. She adds, “We’ve experienced great collaboration with TRT over the last few years, and we look forward to deepening our relationship with them.”

John E. Davies, DSc, CEO of TRT states, “RoosterBio have established themselves as leaders in hMSC bioprocess systems, and we are enthusiastic to apply their scalable, cGMP production platforms to our patented umbilical cord perivascular cellular (TXP) technology. We believe that our TXP technology has unique advantages over other mesenchymal cell sources, and leveraging RoosterBio’s scalable manufacturing platforms will accelerate our therapeutic programs. Overall, this is a collaboration with far reaching implications in the fields of Regenerative Medicine and Cellular Therapy.”

About RoosterBio, Inc.:
RoosterBio, Inc. is a privately held stem cell tools and technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and well-characterized adult hMSCs paired with highly engineered bioprocess media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio and adult stem cells, please visit http://www.roosterbio.com, follow on twitter (@RoosterBio), or read the blog “Democratizing Cell Technologies” (http://www.roosterbio.blogspot.com).

About Tissue Regeneration Therapeutics Inc.:
TRT is a Canadian Controlled Private Corporation (CCPC) with a focus on the commercial development of their patented Human Umbilical Cord PeriVascular Cell (HUCPVC) technology platforms that include culture expanded cells (TXP) and engineered cells (eTXP). The latter are designed for specific unmet needs, in addition to the constitutive advantages of TXP, by the engineered secretion of cytokines, growth factors or monoclonal antibodies for targeted therapies. TRT is the first company in the world to have issued and allowed patents in the USA, Europe and Australasia, for extraction of these unique cells from umbilical cord tissue, and their gene engineering. Additional information is available at http://www.verypowerfulbiology.com.

Read the full story at https://www.prweb.com/releases/roosterbio_inc_and_tissue_regeneration_therapeutics_inc_announce_alliance_around_scale_up_manufacturing_of_umbilical_cord_tissue_perivascular_cell_technology/prweb15976335.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. RoosterBio, Inc. Earns NIIMBL Nod with 2 Grant Awards for Regenerative Medicine Manufacturing
2. Scientist.com and ZenBio, Inc. Partner to Offer Researchers Online Access to Human Skin Tissue for Screening Cosmetics and Personal Care Products
3. Asymmetrex Proposes “Stemgene Therapy” to Emphasize the Importance of Tissue Stem Cells for Successful Gene Therapy
4. Improving imaging of cancerous tissues by reversing time
5. First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved
6. UW-Madison team developing tissue chip to screen neurological toxins
7. NIH funds next phase of Tissue Chip for Drug Screening program
8. The mechanics of tissue growth
9. K-to-M histone mutations: How repressing the repressors may drive tissue-specific cancers
10. New technology may identify tiny strains in body tissues before injuries occur
11. Tissue regeneration using anti-inflammatory nanomolecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2019)... ... May 23, 2019 , ... Inference ... and service organizations, today announced its inclusion in DMG Consulting’s 2019-2020 Intelligent Virtual ... virtual agent (IVA) market share leader, based on number of customers, with 15.8% ...
(Date:5/21/2019)... Mass. (PRWEB) , ... May 21, 2019 , ... ... into the environment, how will we know? How can we tell it apart ... challenge being taken on by a multi-institution research team, including Eric Young ...
(Date:5/21/2019)... CONSHOHOCKEN, Pa. (PRWEB) , ... May 21, 2019 , ... ... trial randomization and drug supply chain management, has been named one of Inc. Magazine’s ... , The full list , now featured on Inc.com and hitting the newsstands ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance ... on July 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is ... , The training will kick off with a compendial treatment of Data Integrity ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study ... efficient delivery system for the sustained release of human placental stem cell (HPSC)-derived ... was able to deliver CM into the injured kidney, where it helped restore ...
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & Biosciences (DuPont) ... Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and discussing best ... supported through a partnership with “Ethiopia Invest”, will run through May 23, 2019, ...
Breaking Biology Technology: